Piramal Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 1,483.31 | 1,239.58 | 1,672.75 |
| Operating Expense | 1,173.88 | 1,008.01 | 1,251.28 |
| Net Profit | 170.74 | 113.48 | 261.63 |
| Net Profit Margin | 11.51% | 9.15% | 15.64% |
| Earning Per Share | 1.29 | 0.85 | 1.97 |
| EBIDTA | 294.90 | 220.50 | 394.36 |
| Effective Tax Rate | 12.71% | 10.77% | 10.23% |
Particulars
Sep 2026
Revenue1,483.31
Operating Expense1,173.88
Net Profit170.74
Net Profit Margin11.51
Earning Per Share1.29
EBIDTA294.90
Effective Tax Rate12.71
